Progress in research of risk factors for atrial fibrillation in hypertrophic cardiomyopathy

doi:10.3877/cma.j.issn.1674-0785.2021.05.014

Abstract

Abstract:

Atrial fibrillation (AF) is the most common arrhythmia in hypertrophic cardiomyopathy (HCM). Patients with HCM have poor tolerance to AF, and patients with HCM and AF have significantly increased risk of mortality and thromboembolic events. Early and accurate identification of the possible risk factors and mechanisms of AF as well as early intervention and treatment can significantly improve the prognosis of such patients. This article reviews the risk factors for AF in HCM.

Key words: Atrial fibrillation, Hypertrophic cardiomyopathy, Risk factors

Juan Wang, Yanmin Yang. Progress in research of risk factors for atrial fibrillation in hypertrophic cardiomyopathy[J]. Chinese Journal of Clinicians(Electronic Edition), 2021, 15(05): 388-392.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2021.05.014

https://zhlcyszz.cma-cmc.com.cn/EN/Y2021/V15/I05/388

Figures/Tables 1

References 41

1	Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC) [J]. Eur Heart J, 2014, 35(39): 2733-2779.
2	Maron BJ, Rowin EJ, Maron MS. Global burden of hypertrophic cardiomyopathy [J]. JACC Heart Failure, 2018, 6(5): 376-378.
3	中华医学会心血管病学分会中国成人肥厚型心肌病诊断与治疗指南编写组, 中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南 [J]. 中华心血管病杂志, 2017, 45(12): 1015-1032.
4	Philipson DJ, Rader F, Siegel RJ. Risk factors for atrial fibrillation in hypertrophic cardiomyopathy [J]. Eur J Prev Cardiol, 2021,28(6):658-665.
5	Guttmann OP, Pavlou M, O'Mahony C, et al. Predictors of atrial fibrillation in hypertrophic cardiomyopathy [J]. Heart, 2017, 103(9): 672-678.
6	Rowin EJ, Hausvater A, Link MS, et al. Clinical profile and consequences of atrial fibrillation in hypertrophic cardiomyopathy [J]. Circulation, 2017, 136(25): 2420-2436.
7	Gruver EJ, Fatkin D, Dodds GA, et al. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation [J]. Am J Cardiol, 1999, 83(12A): 13H-18H.
8	Lee S, Ashley EA, Homburger J, et al. Incident atrial fibrillation is associated with MYH7 sarcomeric gene variation in hypertrophic cardiomyopathy [J]. Circ Heart Fail, 2018,11(9): e005191.
9	Ho CY, López B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy [J]. N Engl J Med, 2010, 363(6): 552-563.
10	Girolami F, Iascone M, Tomberli B, et al. Novel alpha-actinin 2 variant associated with familial hypertrophic cardiomyopathy and juvenile atrial arrhythmias: a massively parallel sequencing study [J]. Circ Cardiovasc Genet, 2014, 7(6): 741-750.
11	Belenkov YN, Privalova EV, Kaplunova VY, et al. Analysis of morpho-functional parameters of the heart and polymorphisms of renin-angiotensin-aldosterone system genes in patients with different variants of the course of hypertrophic cardiomyopathy [J]. Kardiologiia, 2010, 50(6): 27-34.
12	Orenes-Pinero E, Hernandez-Romero D, Romero-Aniorte AI, et al. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy [J]. QJM, 2014, 107(8): 613-621.
13	Haruki S, Minami Y, Hagiwara N. Stroke and embolic events in hypertrophic cardiomyopathy: risk stratification in patients without atrial fibrillation [J]. Stroke, 2016, 47(4): 936-942.
14	Guttmann OP, Rahman MS, O'Mahony C, et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review [J]. Heart, 2014, 100(6): 465-472.
15	Debonnaire P, Joyce E, Hiemstra Y, et al. Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation [J]. Circ Arrhythm Electrophysiol, 2017, 10(2):e004052.
16	Fukumoto K, Habibi M, Ipek EG, et al. Association of left atrial local conduction velocity with late gadolinium enhancement on cardiac magnetic resonance in patients with atrial fibrillation [J]. Circ Arrhythm Electrophysiol, 2016, 9(3): e2897.
17	Kuppahally SS, Akoum N, Burgon NS, et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI [J]. Circ Cardiovasc Imaging, 2010, 3(3): 231-239.
18	Sivalokanathan S, Zghaib T, Greenland GV, et al. Hypertrophic cardiomyopathy patients with paroxysmal atrial fibrillation have a high burden of left atrial fibrosis by cardiac magnetic resonance imaging [J] JACC Clin Electrophysiol, 2019, 5(3): 364-375.
19	Cecchi F, Montereggi A, Olivotto I, et al. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration [J]. Heart, 1997, 78(1): 44-49.
20	Tuluce K, Yakar TS, Kahya EN, et al. Predictors of future atrial fibrillation development in patients with hypertrophic cardiomyopathy: a prospective follow-up study [J]. Echocardiography, 2016, 33(3): 379-385.
21	Ozdemir O, Soylu M, Demir AD, et al. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy [J]. Int J Cardiol, 2004, 94(2-3): 163-166.
22	Farhad H, Seidelmann SB, Vigneault D, et al. Left atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy [J]. J Cardiovasc Magn Reson, 2017, 19(1): 107.
23	Debonnaire P, Joyce E, Hiemstra Y, et al. Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation [J]. Circ Arrhythm Electrophysiol, 2017, 10(2): e004052.
24	Maron BJ, Haas TS, Maron MS, et al. Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance [J]. Am J Cardiol, 2014, 113(8): 1394-1400.
25	Paraskevaidis IA, Farmakis D, Papadopoulos C, et al. Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study [J]. Am Heart J, 2009, 158(3): 444-450.
26	Paraskevaidis IA, Panou F, Papadopoulos C, et al. Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study [J]. Heart, 2009, 95(6): 483-489.
27	Girasis C, Vassilikos V, Efthimiadis GK, et al. Patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation: advanced echocardiographic evaluation of the left atrium combined with non-invasive P-wave analysis [J]. Eur Heart J Cardiovasc Imaging, 2013, 14(5): 425-434.
28	Garg L, Gupta M, Sabzwari SRA, et al. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management [J]. Heart Fail Rev, 2019, 24(2): 189-197.
29	Pedrosa RP, Drager LF, Genta PR, et al. Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy [J]. Chest, 2010, 137(5): 1078-1084.
30	Oliveira W, Campos O, Bezerra LE, et al. Left atrial volume and function in patients with obstructive sleep apnea assessed by real-time three-dimensional echocardiography [J]. J Am Soc Echocardiogr, 2008, 21(12): 1355-1361.
31	Van Wagoner DR, Chung MK. Inflammation, inflammasome activation, and atrial fibrillation [J]. Circulation, 2018, 138(20): 2243-2246.
32	Liu L, Wu L, Zheng L, et al. Associations between multiple circulating biomarkers and the presence of atrial fibrillation in hypertrophic cardiomyopathy with or without left ventricular outflow tract obstruction [J]. Int Heart J, 2019, 60(2):327-335.
33	Fang L, Ellims AH, Beale AL, et al. Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy [J]. Am J Transl Res, 2017, 9(11): 5063.
34	Baumgartner C, Da CB, Collet TH, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation [J]. Circulation, 2017, 136(22): 2100-2116.
35	孟祥彬. 甲状腺功能对肥厚型心肌病患者发生房颤以及远期预后的影响 [D]. 郑州: 郑州大学, 2018.
36	Liu LM, Shen LS, Liu SY, et al. Correlations between low thyroid function and incidence of atrial fibrillation in hypertrophic obstructive cardiomyopathy [J]. Chronic Dis Transl Med, 2020, 6(1): 35-45.
37	Liu L, Yun F, Zhao H, et al. Atrial sympathetic remodeling in experimental hyperthyroidism and hypothyroidism rats [J]. Int J Cardiol, 2015, 187: 148-150.
38	Zhang Y, Dedkov EI, Teplitsky D, et al. Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats [J]. Circ Arrhythm Electrophysiol, 2013, 6(5): 952-959.
39	Siontis KC, Geske JB, Ong K, et al. Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical correlations, and mortality in a large high-risk population [J]. J Am Heart Assoc, 2014, 3(3): e1002.
40	Tuluce K, Yakar TS, Kahya EN, et al. Predictors of future atrial fibrillation development in patients with hypertrophic cardiomyopathy: a prospective follow-up study [J]. Echocardiography, 2016, 33(3): 379-385.
41	Mayyas F, Niebauer M, Zurick A, et al. Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease [J]. Circ Arrhythm Electrophysiol, 2010, 3(4): 369-379.

[1]	Huanyan Liu, Yang Hua, Lingyun Jia, Xinyu Zhao, Beibei Liu. Lumen structure and hemodynamic characteristics of occluded internal carotid artery [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 809-815.
[2]	Yanbo Ma, Yang Hua, Guimei Liu, Xiufeng Meng, Liping Cui. Risk factors for carotid atherosclerotic lesions in middle adults [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 822-826.
[3]	Danni Liu, Meng Ao, Haitao Ran, Shiyu Li, Fang Qin. Biatrial structure and function reverse remodelling in patients with persistent atrial fibrillation after cardioversion: evidence from three dimensional echocardiography and two dimensional speckle tracking imaging [J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(08): 827-835.
[4]	Yingxiong Huang, Zi Ye, Peng Jiang, Hong Zhan, Chen Yao, Ji Cui. Clinical risk factors for transmural intestinal necrosis in acute mesenteric venous thrombosis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 413-421.
[5]	Zaibo Zhang, Bingyu Wang, Zhikai Jiao, Bibo Tan. Risk factors for lower extremity deep venous thrombosis after gastric cancer surgery: A Meta-analysis [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(06): 475-480.
[6]	Xu Tang, Bing Han, Wei Liu, Ruxing Chen. Analysis of risk factors for metachronous liver metastases after radical colorectal cancer surgery and construction of a predictive model [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 16-20.
[7]	Fangyuan Wu, Xia Sun, Changfeng Lin, Zhensheng Zhang. Risk factors of HBV-associated cirrhosis complicated with acute upper gastrointestinal bleeding [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 45-47.
[8]	Qingyan Yan, Xiaomei Yong, Hong Luo, Min Du. Prognostic factors and survival analysis of multicenter elderly patients with metastatic breast cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 636-638.
[9]	Xian Mo, Chuang Yang. Meta-analysis of risk factors for portal vein thrombosis in patients with cirrhosis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 678-683.
[10]	Yonghuan Mao, Hanwen Tong, Ji Miao, Xingzhou Wang, Xiaofei Shen, Chunzhao Yu. Analysis of risk factors and prediction model of parastomal hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(06): 682-687.
[11]	Menggui Lu, Bin Huang, Qiulin Li, Yuanmei He. Risk factors for multiple organ dysfunction syndrome in patients with bee sting injury [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(9): 1010-1015.
[12]	Da Li, Daya Zhang, Runxiang Chen, Xiaodong Zhang, Shimei Huang, Chen Chen, fan Zeng, Shiju Chen, Feihu Bai. Epidemiological characteristics and risk factors of Helicobacter pylori infection in Dongfang city of Hainan province [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 858-864.
[13]	Ke Meng, Yan Li, Jingshuang Yan, Bin Yan. Risk factors for prolonged gastric transit time in capsule endoscopy [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 671-675.
[14]	Yanli Yang, Yu Chen, Ruochen Zhao, Wei Du, Haijuan Ma, Ke Xu, Liyun Zhang. Bloodstream infection in patients with systemic lupus erythematosus: risk factors and bacteriological analysis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 694-699.
[15]	Peipei Sun, Erming Zhang, Yanwei Shi, Chunyan Zhao, Pingping Song, Shuo Zhang, Ke Zhang, Yujiao Zhou, Can Zhao, Wei Yan, Rongju Wu, Liping Song, Weian Guo, Shitou Ma, Xinhua An, Caoxin Bao, Pingchao Xiang. Prevalence and risk factors of chronic obstructive pulmonary disease in residents aged 40 years and above in Shijingshan district of Beijing [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 711-719.

Please choose a citation manager

Content to export